Study of CMTS1215 Injection in Patients With Solid Tumors

Summary

This is a prospective, open-label, single-arm exploratory clinical trial to evaluate the safety and efficacy of CMTS1215 (Proteus mirabilis) oncolytic bacteria injection for the treatment of solid tumors. The study aims to enroll at least 8 patients with histologically confirmed solid tumors who have failed or are unable to complete conventional first-line, second-line, or third-line anti-tumor therapies.

Timeline

Start

2025-03-06

Primary completion

2030-12-31

Completion

2030-12-31

Drugs

Indications